A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

Tracks what the 30 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors

Vacancies

We are a fast-paced international team with diverse academic and professional backgrounds. We work every day to change how pharmaceutical companies bring their medicines to the poor. Today, millions of people have yet to benefit fully from modern medicine. If you think you would be a good fit for the vacancies shown here, then please get in touch.

Access to Medicine Foundation - 15 Apr 2020

Director of Research Operations

The Access to Medicine Foundation is looking for an experienced Director of Research Operations to oversee all research programmes undertaken by the A...

Read more
Access to Medicine Index - 15 Apr 2020

Researchers

The Access to Medicine Foundation is strengthening its research capacity and is in search of two trained pharmacists to join our team as researchers m...

Read more

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.

Back to top |